|
Removal from Official List - Annual Listing Fees
|
29 August 2022 at 10:59am
|
|
Suspension from Official Quotation - Annual Listing Fees
|
22 August 2022 at 11:50am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 July 2022 at 9:35am
|
|
Business Restructure
|
1 June 2022 at 8:55am
|
|
Appendix 3Z
|
26 May 2022 at 10:59am
|
|
Appendix 3Z
|
26 May 2022 at 10:59am
|
|
Board Composition and Annual Meeting Updates
|
26 May 2022 at 10:45am
|
|
Extension to voluntary suspension
|
10 May 2022 at 10:25am
|
|
Update from Osprey
|
6 May 2022 at 10:15am
|
|
Voluntary Suspension
|
3 May 2022 at 9:25am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 April 2022 at 2:55pm
|
|
Trading Halt
|
29 April 2022 at 9:40am
|
|
Revised date for release of Quarterly Results
|
27 April 2022 at 1:45pm
|
|
Quarterly Results and Investor Conference Call Notification
|
21 April 2022 at 1:05pm
|
|
Appendix 4G
|
21 April 2022 at 9:20am
|
|
Corporate Governance Statement
|
21 April 2022 at 9:20am
|
|
Annual Report to Stockholders
|
21 April 2022 at 9:20am
|
|
Osprey Medical Financial Results for FY2021
|
28 February 2022 at 9:25am
|
|
Appendix 4E and FY2021 Consolidated Financial Statements
|
28 February 2022 at 9:20am
|
|
Annual Meeting of Stockholders
|
1 February 2022 at 10:10am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 January 2022 at 9:10am
|
|
Quarterly Results and Investor Conference Call Notification
|
24 January 2022 at 8:40am
|
|
Notification of cessation of securities - OSP
|
21 December 2021 at 9:40am
|
|
CEO Investor Presentation
|
25 November 2021 at 8:50am
|
|
Notification regarding unquoted securities - OSP
|
3 November 2021 at 2:30pm
|
|
DyeVert highlighted by leading experts for reduction of AKI
|
28 October 2021 at 9:20am
|
|
Appendix 4C
|
20 October 2021 at 8:50am
|
|
Notification regarding unquoted securities - OSP
|
14 October 2021 at 9:35am
|
|
Quarterly Results and Investor Conference Call Notification
|
13 October 2021 at 8:50am
|
|
Osprey Technology Featured at Italian Cardiology Meeting
|
11 October 2021 at 9:30am
|
|
Appendix 3Y
|
30 September 2021 at 10:15am
|
|
Appendix 3Y
|
30 September 2021 at 10:15am
|
|
Notification regarding unquoted securities - OSP
|
30 September 2021 at 10:15am
|
|
Reverse Stock Split and Dispatch of Holding Statements
|
23 September 2021 at 10:20am
|
|
GE ramps up promotion of Osprey DyeVert System across Europe
|
23 September 2021 at 9:35am
|
|
Results of Special Meeting of Stockholders
|
3 September 2021 at 1:40pm
|
|
Update - Consolidation/Split - OSP
|
3 September 2021 at 1:35pm
|
|
Notification of cessation of securities - OSP
|
1 September 2021 at 8:55am
|
|
Consolidation/Split - OSP
|
20 August 2021 at 9:15am
|
|
Notice of Special Meeting of Stockholders
|
20 August 2021 at 9:15am
|
|
Global expansion strategy progress strengthens revenues
|
17 August 2021 at 9:00am
|
|
Appendix 4D Half Year Report & Accounts
|
17 August 2021 at 8:55am
|
|
Appendix 3X
|
12 August 2021 at 9:20am
|
|
Martin Emerson appointed to Osprey Medical Board
|
12 August 2021 at 9:20am
|
|
Notification of cessation of securities - OSP
|
2 August 2021 at 9:40am
|
|
Appendix 4C
|
29 July 2021 at 8:45am
|
|
Quarterly Results and Investor Conference Call Notification
|
22 July 2021 at 9:20am
|
|
Canadian Expansion and exclusive GE distribution agreement
|
20 July 2021 at 9:40am
|
|
Notification regarding unquoted securities - OSP
|
12 July 2021 at 9:45am
|
|
Appendix 3Y
|
12 July 2021 at 9:20am
|
Osprey Medical, Inc